Press Releases

  • Study reveals six depression subtypes

    Brain imaging, known as functional MRI, combined with machine learning can predict a treatment response based on one’s depression “biotype.”…

  • Low risk of cancer after CAR-T therapy

    In April, the FDA warned of risk of secondary cancers in people receiving CAR-T cell therapy. A large Stanford Medicine study finds the risk is low and not related to the CAR-T cells.

  • No Paxlovid benefit seen for long COVID

    Paxlovid, effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in this single-center study. But further research may show benefits with different doses or for people with specific symptoms.

  • Myelination may drive drug addiction

    New research in mice by Stanford Medicine scientists has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

  • Foretelling breast cancer

    In a finding that vastly expands the understanding of tumor evolution, researchers discover genetic biomarkers that can predict the breast cancer subtype a patient is likely to develop.

  • George Hahn dies at 98

    A personal tragedy spurred Hahn, who had escaped Nazi Europe as a child, to pursue a career seeking new therapies for cancer.

  • Sleep timing affects mental health

    In a new, large-scale study of sleep behavior, Stanford Medicine scientists found that night owls don’t really thrive late at night.

  • Sustainable Healthcare certification

    Stanford Health Care is among the first health care organizations in the nation to receive the certification, which celebrates its progress toward reducing emissions that contribute to climate change.

  • Register for RAISE Health symposium

    Register for the inaugural RAISE Health symposium, which will convene leaders in artificial intelligence for discussions on safe and responsible AI innovation.

  • Pump for kids’ failing hearts

    A new type of surgically implanted pump that can support a child’s failing heart has passed the first stage of human testing in a Stanford Medicine-led trial.


2024 ISSUE 1

Psychiatry’s new frontiers